114 related articles for article (PubMed ID: 8598696)
1. Reconsidering an attenuated vaccine for AIDS.
Beale J
Lancet; 1996 Feb; 347(8998):344-5. PubMed ID: 8598696
[No Abstract] [Full Text] [Related]
2. SIV vaccine for AIDS.
Farthing CF; Sullivan JL
Science; 1998 Jan; 279(5347):14-5. PubMed ID: 9441400
[No Abstract] [Full Text] [Related]
3. 1999: a time to re-evaluate AIDS vaccine strategies.
Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
[TBL] [Abstract][Full Text] [Related]
4. Is the Nef protein of HIV-1 required for pathogenesis?
Miller MD; Greene WC
Trends Microbiol; 1996 May; 4(5):171-2; discussion 173. PubMed ID: 8727595
[No Abstract] [Full Text] [Related]
5. Live HIV vaccines--how safe?
Dittmer U; Stahl-Hennig C; Hunsmann G
Nat Med; 1997 Aug; 3(8):816. PubMed ID: 9256262
[No Abstract] [Full Text] [Related]
6. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine.
Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412
[No Abstract] [Full Text] [Related]
7. An attenuated vaccine for AIDS?
Beale J
Lancet; 1995 May; 345(8961):1318-9. PubMed ID: 7752750
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.
Sawai ET; Hamza MS; Ye M; Shaw KE; Luciw PA
J Virol; 2000 Feb; 74(4):2038-45. PubMed ID: 10644378
[TBL] [Abstract][Full Text] [Related]
9. Attenuated retrovirus vaccines and AIDS.
Van Rompay KK; Spinner A; Otsyula M; McChesney MB; Marthas ML
Science; 1995 Nov; 270(5239):1218-9; author reply 1220-2. PubMed ID: 7502051
[No Abstract] [Full Text] [Related]
10. Attenuated HIV vaccine: caveats.
Ruprecht RM; Baba TW; Liska V
Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
[No Abstract] [Full Text] [Related]
11. Attenuated retrovirus vaccines and AIDS.
Shearer GM; Lucey DR; Clerici M
Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
[No Abstract] [Full Text] [Related]
12. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
[TBL] [Abstract][Full Text] [Related]
13. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
14. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
[TBL] [Abstract][Full Text] [Related]
15. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.
Gundlach BR; Lewis MG; Sopper S; Schnell T; Sodroski J; Stahl-Hennig C; Uberla K
J Virol; 2000 Apr; 74(8):3537-42. PubMed ID: 10729127
[TBL] [Abstract][Full Text] [Related]
16. AIDS doctors push for live-virus vaccine trials.
McCarthy M
Lancet; 1997 Oct; 350(9084):1082. PubMed ID: 10213561
[No Abstract] [Full Text] [Related]
17. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
18. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus.
Sharpe SA; Whatmore AM; Hall GA; Cranage MP
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1923-7. PubMed ID: 9266989
[TBL] [Abstract][Full Text] [Related]
19. A candidate live inactivatable attenuated vaccine for AIDS.
Chakrabarti BK; Maitra RK; Ma XZ; Kestler HW
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9810-5. PubMed ID: 8790413
[TBL] [Abstract][Full Text] [Related]
20. Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
Gabriel B; Fiebig U; Hohn O; Plesker R; Coulibaly C; Cichutek K; Mühlebach MD; Bannert N; Kurth R; Norley S
Virology; 2016 Feb; 489():1-11. PubMed ID: 26685794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
